Information Journal Paper
APA:
Copy. (2018). Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT. Efficacy and Mechanism Evaluation Journal, 5(-), 0-0. SID. https://sid.ir/paper/776747/en
Vancouver:
Copy. Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT. Efficacy and Mechanism Evaluation Journal[Internet]. 2018;5(-):0-0. Available from: https://sid.ir/paper/776747/en
IEEE:
Copy, “Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT,” Efficacy and Mechanism Evaluation Journal, vol. 5, no. -, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/776747/en